MedTrace Logo

Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits

NCT02292576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-11-17

No results posted yet for this study

Summary

Evaluate if gene expression changes in SOD2 explain the health benefits of high polyphenols cocoa

Conditions

  • Healthy

Interventions

OTHER

Cocoa Pure

Cocoa Pure.

OTHER

Placebo

Placebo.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Maria Elizabeth Tejero Barrera, Ph.D. · Instituto Nacional de Medicina Genomica

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-04-30
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292576 on ClinicalTrials.gov